Cargando…
In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target
New treatments for diseases caused by antimicrobial-resistant microorganisms can be developed by identifying unexplored therapeutic targets and by designing efficient drug screening protocols. In this study, we have screened a library of compounds to find ligands for the flavin-adenine dinucleotide...
Autores principales: | Lans, Isaias, Anoz-Carbonell, Ernesto, Palacio-Rodríguez, Karen, Aínsa, José Antonio, Medina, Milagros, Cossio, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449411/ https://www.ncbi.nlm.nih.gov/pubmed/32797038 http://dx.doi.org/10.1371/journal.pcbi.1007898 |
Ejemplares similares
-
Discovery of antimicrobial compounds targeting bacterial type FAD synthetases
por: Sebastián, María, et al.
Publicado: (2017) -
Cofactors and pathogens: Flavin mononucleotide and flavin adenine dinucleotide (FAD) biosynthesis by the FAD synthase from Brucella ovis
por: Moreno, Andrea, et al.
Publicado: (2021) -
Mutation of Aspartate 238 in FAD Synthase Isoform 6 Increases the Specific Activity by Weakening the FAD Binding
por: Leone, Piero, et al.
Publicado: (2019) -
Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles
por: Lans, Isaias, et al.
Publicado: (2020) -
Exponential consensus ranking improves the outcome in docking and receptor ensemble docking
por: Palacio-Rodríguez, Karen, et al.
Publicado: (2019)